The effects of lever positioning manipulation versus schorth exercise in idiopathic scoliosis: a protocol for a randomized clinical trial (RCT)

The effects of lever positioning manipulation versus schorth exercise in idiopathic scoliosis: a protocol for a randomized clinical trial (RCT) | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Study protocol The effects of lever positioning manipulation versus schorth exercise in idiopathic scoliosis: a protocol for a randomized clinical trial (RCT) Zicheng Wei, Kaizheng Wang, Xingchen Zhou, Longhao Chen, Shuang Wu, and 6 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-3848605/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Background: Idiopathic scoliosis is a prevalent clinical condition within the bone and joint system, commonly manifested in adolescents, significantly impacting their physical and mental well-being. Presently, conservative interventions constitute the primary therapeutic approach, encompassing modalities such as brace therapy, manipulation therapy, and exercise therapy. Nonetheless, challenges persist in the realm of conservative treatment, marked by issues of inconvenience and suboptimal adherence. This study endeavors to identify a manipulation technique that can potentially substitute or augment the efficacy of brace therapy or exercise therapy. The primary objective of this protocol is to delineate a randomized controlled trial aimed at scrutinizing and contrasting the outcomes resulting from a specific manipulation method (lever positioning manipulation) and a widely employed exercise therapy (Schroth exercise) in the management of idiopathic scoliosis. Methods： This is a randomized clinical trial, employing both assessor-blinding and analyst-blinding methodologies. This study is proposed to include 102 patients with idiopathic scoliosis. The 102 patients were divided into 2 groups of 51 cases each by randomized number table method. The groups consist of a traditional massage combined with lever positioning manipulation group and a traditional massage combined with Schroth exercise group. Each exercise regimen is administered thrice weekly over an 8-week duration. Outcome measures encompass the assessment of Cobb angle, apical vertebral translation (AVT), muscle tone, pressure pain threshold (PPT), quality of life (SF-36 ) , Oswestry disability index (ODI) and clinical efficiency. Evaluations are conducted at baseline, the conclusion of the treatment program, and during follow-up sessions. It will be observed whether the manipulation is superior compared to the schorth exercise and whether it can be used as an alternative treatment for scoliosis. Discussion: The results of this study will tell clinicians what conservative therapy regimen will produce better clinical outcomes for patients with AIS. Trial registration: This project is registered with the Chinese Clinical Trial Registry，Registration number: ChiCTR2300077604. Idiopathic scoliosis Lever positioning manipulation Protocol Cobb angle Muscle tone Pain threshold Figures Figure 1 Figure 2 Introduction Idiopathic scoliosis is a common clinical disease of the bone and joint system [ 1 ]. Due to some reasons, one or several segments of the spine have deformation, lateral curvature and rotation deformity on the tubular plane that is different from the normal physiological curvature, so that the spine loses its original structure, and is often accompanied by neuromuscular or skeletal diseases [ 2 – 3 ]. Scoliosis can be divided into three main categories from the etiological point of view, which are congenital, neuromyogenic and idiopathic scoliosis, of which idiopathic account for 85%. Clinical treatment often takes into account the growth and development of adolescents and the harm of surgical trauma, and tries to adopt conservative treatment when the Cobb Angle is not greater than 40° [ 4 ]. However, conservative treatment also has several clinical problems, such as brace therapy requires long daily wear to be effective, as well as clinical problems such as long cycles and poor compliance among adolescents [ 5 ]. Schroth exercise represents a targeted corrective training approach designed for scoliosis management [ 6 ]. The underlying principle involves the deliberate alteration of body postures to open up the concave side of the scoliosis, facilitating the extension of the spine along its longitudinal axis. This corrective measure aims to realign the spine as closely as possible to the midline while incorporating helical angular respiration to address the rotational deformities induced by scoliosis and enhance thoracic expansion [ 7 ]. Schroth exercise, as a scoliosis-specific exercise therapy, has a positive significance on scoliosis patients. Its benefits encompass the ability to arrest the progression of scoliotic curves, alleviate lower back pain, augment lung capacity, refine posture, and elevate overall quality of life [ 8 ]. However, Schroth exercise still has shortcomings in the treatment of scoliosis correction. First, this treatment requires patients to train continuously and effectively for a long period of time, and due to the boring training process and the heavy school workload of adolescents, the long-term compliance of patients is poor; second, due to the low age of most patients, it is difficult to grasp the details of each training movement, which often fails to achieve the effect of the training of the target muscle groups [ 9 ]. Therefore, a kind of maneuver with good long-term compliance and low requirements for patients' own cooperation is urgently needed to be explored and tested. Notably, no prior studies have undertaken a comparative analysis between Traditional Chinese Medicine (TCM) manipulation and Schroth therapy, specifically assessing their impacts on muscle tissue condition, pain levels, and overall quality of life. Lever positioning manipulation (LPM) is a complementary therapy for spine-related disorders that is widely used in China [ 10 – 11 ]. LPM is usually performed by a physician trained in specialized manipulation. LPM involves the application of controlled forces by hand to the patient's paravertebral muscles and spine, with the aim of correcting abnormal bone positions and alleviating associated pain. LPM is able to affect sensory and emotional pain management in patients with LDH through prefrontal cortex, and primary somatosensory cortex regions of brain [ 12 ]. Recent investigations in 2021 have substantiated the efficacy of LPM in ameliorating Cobb's angle in LDH patients with the appearance of "scoliosis" [ 13 ]. Building upon this, a subsequent study demonstrated the positive impact of lever positioning manipulation on enhancing spino-pelvic sagittal parameters in individuals with Idiopathic Scoliosis (IS) [ 14 ]. As an external treatment of traditional Chinese medicine, leverage positioning technique has a good clinical effect on idiopathic scoliosis, which has been confirmed in the preliminary clinical study. Therefore, the purpose of this clinical trial was to evaluate and compare the effects of two treatment regimens on Cobb angle, apical vertebral translation (AVT), muscle tone, pressure pain threshold (PPT), quality of life (SF-36 ) , Oswestry disability index (ODI) and clinical efficiency in patients with AIS. Methods Study design: The study will recruit 102 subjects aged 12–45 years from patients diagnosed with idiopathic scoliosis in the Third Hospital of Zhejiang University of Traditional Chinese Medicine. The researcher will divide the eligible subjects into 2 groups by using a randomized numeric table. Each group would receive the corresponding intervention, each exercise program was performed three times a week and continued for 8 weeks. Outcome indicators would be assessed before and after intervention. A detailed account of the examinations, tests, or interventions administered at various time points is provided in Table 1 . Result Data integration, processing and analysis will be performed by different designated researchers in this project at the end of all interventions as well as follow-up processes. The flowchart of this experiment is shown in Fig. 1 . Participants : This study will recruit IS patients who meet diagnostic criteria and eligibility criteria. Recruitment will be carried out by a single physician and an informed conversation will take place either in the consultation room or in the reception room of the wards. Participation in this study is entirely voluntary and patients may refuse to participate in this study or withdraw from the trial at any time without penalty or loss of benefits. If there is any important new information during the course of the trial that may affect the patient's willingness to continue participating in the study, the physician will inform the participants promptly. (The patient's legal representative will be notified when the patient is under 18 years of age). Before the patient makes the decision to participate in the trial, the physician will inform the subject of all aspects of the trial, and the subject may ask the physician questions about it until the subject fully understands the trial study. Diagnostic criteria : According to the International Scoliosis Research Society (SRS) standards [ 15 ]: ①adolescents without congenital diseases and a clear history of trauma; ②physical examination: the trunk is obviously asymmetric, the spine is scoliosis deformity; ③imaging: the patient's full-length orthopantomogram of the spine shows that Cobb's angle is ≥ 10°; ④may be accompanied by local pain, aching and swelling and other sensory abnormalities. Eligibility criteria Inclusion criteria ①Meet the diagnostic criteria of scoliosis; ②Age is 12–45 years old; ③Agree to participate in this study, accept the treatment of this program, sign the informed consent form and be able to cooperate with the follow-up; ④Be able to cooperate with the examination of spine radiograph and perform the measurement of Cobb angle and other related indexes; ⑤10° ≤ Cobb angle ≤ 40°; ⑥Patient's scoliotic segment is one of the three of thoracic, thoracolumbar and lumbar segments. Exclusion criteria ①scoliosis progressed to the serious impact on cardiopulmonary function, is not suitable for conservative treatment; ②congenital scoliosis, spinal deformity, or the spine combined with vertebral body slippage, tumors, tuberculosis, bone fracture disease; ③combined with rheumatism, neuromuscular disease, cardiovascular disease, pulmonary disease or renal disease; ④Those who have undergone corrective spinal surgery; ⑤suffering from skin-related diseases and are unable to perform manipulation; ⑥Those who are suffering from mental illness or poor clinical compliance; ⑦Those who have not followed the prescribed treatment and are unable to judge the efficacy of the treatment, or those whose data are incomplete and affect the judgment of the efficacy of the treatment. Table 1 Diagram of research design ×: Indicates that this intervention program is being conducted at this point in timeline Randomization and Blinding : After the patients who meet the diagnostic criteria and have been screened for inclusion and exclusion have agreed to participate in this study, the researcher will group the subjects using a random number table method [ 16 ]. Each enrolled participant will be assigned a number generated through SPSS version 25.0, with each number corresponding to a specific treatment group. An investigator not involved in the intervention step will randomize the enrolled subjects into groups. Manipulations in this study will be performed by an acupuncture and massage practitioner with 5 years of clinical experience. This practitioner will be trained to perform Tuina, lever positioning manipulation, and Schroth exercise. Blinding of patients was not feasible due to the substantial variability in intervention modalities between the lever positioning maneuver and Schroth exercise. Patient blinding was not implemented for routine acupressure maneuvers, ensuring that the practitioner was aware of the patient's name but not their group enrollment. In addition, the intervention, efficacy assessment, and statistical analysis were performed by different designated researchers in this project. Statistical analysis will be performed by a professional statistician. Intervention groups We plan to set up 2 study groups in this study. The interventions that 2 treatment groups will receive are: ①Tuina combine lever positioning manipulation ②Tuina combine schorth exercise Each exercise program was performed three times a week on Sunday, Tuesday, and Thursday of each week. Cobb angle, AVT, muscle tone, PPT, ODI, quality of life, and clinical efficiency would be assessed before and after the "8 weeks" intervention. Intervention manipulation Tuina The patient was placed in the prone position, exposing the back. The doctor used the rolling manipulation with a frequency of 100–120 times/min, the flicking manipulation with a frequency of 120–160 times/min, the pressing and kneading manipulation with a frequency of 120–150 times/min. These manipulations will be operated on the Du channel (GV) and both sides of the Bladder channels (BL) [ 17 ]. Attention was paid to the presence or absence of nodules, spasm points and other abnormal reaction points. Doctor were focused on the treatment for the lesion segments. Then, acupoints on both sides of the spine will be operated by pressing and kneading manipulation, which lasted for about 15 min. The exact location for each point will be determined based on the 2006 People’s Republic of China National Standard: The Name and Location of Acupoints (GB/T 12 346–2006). Lever positioning manipulation The patient is placed in the prone position and the scoliosis area is exposed. Combined with X-ray examination, the scoliosis parietal vertebrae area is used as the positioning point for the doctor's operation. Make the patient relax, keep the lower limbs straight, the assistant hold the patient's knees and raise the patient's lower limbs and bend them toward the convex side of the spine to stretch the concave muscles. Then, the doctor with the elbow eagle's beak positioned next to the patient's parietal vertebrae, ask the patient to open his mouth and exhale. The doctor and the assistant simultaneously apply pressure in the opposite direction to the convex side of the spine at the same time, When pulling upwards to the trigger point, the practitioner pulls with a lever quickly with a technique and then senses a clatter or looseness at the positioning point [ 12 ]. Repeat this procedure 3 times. The doctor and patient need to work closely together, patient should do not hold breath. Finally make the patient supine rest for 30min. The operation diagram of lever positioning manipulation was shown in Fig. 2 . Schroth exercise Take scoliosis with right lateral convexity as an example, the patient takes the natural standing position. If the patient's spine is in three arcs (one main and two compensatory arcs), flex the left hip joint, move the pelvis right under the thoracic convexity side, and support the body with the right leg. If the patient is in four arcs (two main and two compensatory arcs), flex the right hip joint, move the pelvis left under the thoracic concavity side, and support the body with the left leg. Moving the thorax left and stretching the concave side of the spine, direct the gas into the concave side as you inhale and push the convex side of the spine toward the opposite side [ 18 ]. After reaching the desired position breathe in while tightening the trunk muscles forcefully. Repeat 20 times as one treatment, and the course of treatment was the same as the test group. Outcome measures Primary outcome measures Cobb angle Took a standard anterior-posterior standing full spine radiograph [ 19 ] to measure the Cobb angle [ 20 ], the major one curve will be measured. The Cobb angle is the most commonly used indicator of IS. Orthopedic surgeons and physical therapists use the Cobb angle to determine the patient's condition and assign treatment goals, and improvements in the Cobb angle directly reduce the need for surgery [ 21 ]. Muscle tone Studies have shown that paraspinal muscle tone is greater on the concave side than on the convex side in patients with idiopathic scoliosis. The severity of scoliosis is closely related to the asymmetric biomechanical characteristics of the paravertebral muscles [ 22 ]. In this study, muscle tone was measured using the Rapid Muscle Condition Measurement System (Ito Ultrashort Wave Co., Ltd., Japan, OE-220). The procedure was as follows: the room temperature was maintained at 25–28 degrees Celsius, and the subjects were placed in the prone position with the low back exposed. The muscles tested were the erector spinae muscles bilaterally. The dystonia test points were calibrated on the erector spinae muscles at 1.5 cm from the largest segment of the scoliotic scoliosis and at 1.5 cm from the interspace between the upper and lower neighboring segments on each side, three on each side. Pressure pain threshold (PPT) PPT stands as a frequently employed quantitative sensory testing (QST) parameter in the investigation of nociceptive sensitization. This quantifiable indicator, measurable by electronic instruments, possesses the distinct advantage of ease of measurement [ 23 ]. It has been shown that the probability of impaired pain modulation is higher in AIS patients with chronic back pain symptoms. Measurement of the PPT can therefore provide some indication of the ability of different interventions to repair pain modulation [ 24 ]. The PPT is measured in the same way as the Muscle tone. First, pressing the pressure probe vertically to the calibration point, the position was the same as that of the muscle tone. When the subject feels the pressure pain, he/she signals to the doctor, who immediately lifts the pressure probe. The PPT value is the peak value of the pressure. 3 measurements were taken on each side, then take the average value. Clinical efficiency The efficacy evaluation was based on the efficacy evaluation criteria of the 2018 version of the Chinese Medicine Diagnosis and Treatment Program for Adolescent Idiopathic Scoliosis issued by the Chiropractic Branch of the Chinese Society of Traditional Chinese Medicine. After the standard anterior-posterior standing full spine radiograph was taken again after treatment, the Cobb angle was compared before and after treatment. Apparent effect: scoliosis improved by more than 30°; Effective: scoliosis improved by ≥ 5° and ≤ 30°; Ineffective: no improvement in scoliosis after 2 weeks of treatment. Secondary outcome measures Apical vertebral translation (AVT) The main apical vertebral translation was measured by a standard anterior-posterior standing full spine radiograph. the AVT for thoracic curvature patients being the horizontal distance from the midpoint of the parietal vertebrae (or discs) to C7PL; and for thoracolumbar curvature and lumbar curvature being the AVT from the midpoint of the parietal vertebrae (or discs) to the CSVL horizontal distance. The left side of the parietal vertebrae bias toward the CSLV/C7PL is negative and the right side is positive [ 25 ]. AVT can be used to determine the stability of the coronal position of the spine and has great significance in patients with scoliosis. Quality of life(SF-36) The Medical Outcomes Study (MOS) Short Form Health Survey, commonly known as SF-36, serves as a concise health survey questionnaire. This instrument comprehensively assesses the quality of life across eight dimensions, encompassing physiological functioning, physical functioning, physical pain, general health status, energy, social functioning, emotional functioning, and mental health. In addition to these dimensions, SF-36 incorporates another health indicator—health change, designed to evaluate the overall change in health status experienced by respondents over the past year [ 26 ]. Oswestry disability index(ODI) The ODI is currently the more commonly used assessment indicatorin the management of spinal disorders [ 27 ]. This scale assesses the level of low back pain, lumbar mobility function in patients with scoliosis and has been shown to be reliable in several studies [ 28 – 29 ]. Sample size : Cobb's angle was used as the primary outcome indicator in this study, and we performed sample size estimation by comparing the mean difference(MD) and standard deviation (SD) of this indicator in two independent samples. We are based on relevant research [ 30 ]. The MD of Cobb angle in group of lever positioning manipulation is 9.69 and the SD was 6.02. the MD of Cobb angle in control group is 13.84 and the SD was 8.21. we set type I error probability α = 0.05, type II error probability β = 0.20, dropout rate = 0.15, bilateral testing, a total of 51 participants were calculated to be recruited in each group. Statistical analysis: All statistical analyses were conducted utilizing SPSS version 25.0. The comparison of subject measures employed either independent samples t-test or Mann-Whitney U-test (α = 0.05), as appropriate, while repeated-measures ANOVA was employed for assessments at multiple time points within groups. For demographic characteristics such as age and BMI, as well as primary outcomes, data normality was confirmed through Q-Q plots and Shapiro-Wilk tests. Count data, specifically the male-to-female ratio, underwent comparison via the chi-square test and Fisher's exact test, considering a two-sided p < 0.05 as indicative of a statistically significant difference. Safety evaluation : Any adverse medical event observed between the subject's informed consent signing and the final visit, irrespective of its causal relationship to the trial, is classified as an adverse event. An adverse event encompasses any unfavorable and undesired sign, symptom, or transient illness associated with treatment, regardless of its causal link to the intervention. Adverse events include the following: all suspected adverse reactions; soreness and discomfort in the lower back; obviously unrelated diseases, including exacerbations of pre-existing conditions; and abnormalities in physical examinations or laboratory tests requiring further investigations (excluding retesting). A serious adverse event is defined as an occurrence during the study phase meeting one or more of the following criteria: death; being life-threatening; necessitating hospitalization or prolonged hospital stay; causing permanent or severe disability; or resulting in a congenital malformation or defect. Medical events that have not yet resulted in death, life-threatening conditions, or the need for hospitalization should also be deemed serious adverse events when deemed appropriate based on medical judgment. Acquisition, observation and recording of adverse events : Clinicians are required to promptly report all adverse events directly observed or spontaneously disclosed by the subjects, utilizing concise medical terminology. Additionally, subjects should be queried about adverse events each time they are assessed post the initiation of treatment to systematically gather trial data. In the occurrence of an adverse event, meticulous records must document the date of onset and resolution, the severity and outcome of the adverse event, a detailed description of the interventions employed, their causal relationship to the administered therapy, and any alternative factors unrelated to the therapy that may have contributed to the adverse event. Treatment of adverse events : If any adverse event occurs during the clinical trial, regardless of whether it is causally related to the treatment method used, the investigator should take necessary measures to provide treatment and rescue. For adverse events, the type, degree, time of occurrence, duration, treatment measures, treatment process, etc. should be recorded in the hospitalized medical record and pathological report form, and comprehensively analyzed whether they are related to the trial. After the occurrence of an adverse event, the investigator may decide whether the subject should be terminated from the clinical trial according to the condition. Cases in which the trial was terminated due to serious adverse events should be tracked and followed up, and their regression should be recorded. In the event of a serious adverse event during the trial, regardless of whether it is related to the trial or not, first aid measures should be taken immediately and the principal investigator and the ethics committee should be notified by telephone within 24 hours. A serious adverse event report form should then be completed and promptly reported to the above authorities. Data collection and monitoring : Upon participant recruitment, the screener will gather baseline characteristic data and conduct measurements of both primary and secondary outcome indicators. Following the completion of the treatment period, the screener will reassess the primary and secondary outcome indicators, with all pertinent data meticulously recorded in the Case Report Form (CRF). During the follow-up visit after 60 days, participants will be requested to complete two questionnaires related to secondary outcome indicators, and the questionnaire results will be documented in the CRF. To ensure data accuracy and integrity, two data managers, blinded to the group assignments, will independently receive and enter completed CRF into an Excel database. These data managers have undergone rigorous training in data monitoring. Additionally, real-time data entry will be performed in the China Clinical Trial Registry, and an electronic data management system will facilitate continuous tracking and monitoring of test data at the Third Hospital Affiliated to Zhejiang University of Traditional Chinese Medicine. Quality control Uniform testing standard operating procedures (SOP) will be developed by the study group. One month before the official launch of the clinical trial, the research group will hold a special training meeting to provide unified training for all researchers involved in the study. The main focus of the training is on the implementation of the program and the standard operating procedures (SOP). So that each clinical researcher is familiar with the research process and specific implementation details to ensure the reliability of the conclusions of the clinical study. All observations in the clinical study should be verified and repeatedly confirmed to ensure the reliability and originality of the data, and to ensure that all results and conclusions in the clinical study are derived from the original data. Specialized personnel should be employed for the collection of trial data and statistics to control trial bias. Appoint a professional data management company for clinical data management. Strictly implement the monthly clinical study quality inspection. Ethics The study was approved by the medical ethics committee of the Third Hospital of Zhejiang University of Traditional Chinese Medicine (No. ZSLL-KY-2023-051-01). And this project was registered with the Chinese Clinical Trial Registry (Registration number: ChiCTR2300077604.). Patient and public involvement Patients and/or the public were not involved in the design, conduct, reporting, or dissemination plans for this study. Dissemination The study will be disseminated through presentations in peer-reviewed international journals and at national and international conferences. Discussion The incidence of adolescent idiopathic scoliosis (AIS) is on the rise, with a prevalence rate approximately twice as high in females as in males [ 31 ]. Only 0.7% of patients underwent surgical treatment within five years of onset due to clinical considerations of adolescent growth and development as well as the hazards of surgical trauma [ 32 ]. For AIS patients with a Cobb angle below 40°, conservative treatment remains the preferred option for the majority. Despite its widespread prevalence, the current evidential support for conservative treatment approaches for AIS is notably lacking. Alongside Schroth therapy, various mainstream exercise therapies, such as DoboMed therapy, have demonstrated the ability to impede the progression of the scoliotic curve, enhance respiratory function, and improve overall exercise efficiency [ 33 ]. In a study by Mamyama T et al [ 34 ], Side-Shift therapy was found to be more efficacious in treating IS after skeletal maturation. However, certain exercise therapies exhibit inconsistent therapeutic effects, with varying efficacy observed among individuals in research studies [ 35 ]. Consequently, there is a compelling need to explore conservative therapies with more reliable and stabilizing effects. LPM is a treatment method in which the physician performs the manipulation and the patient's body undergoes passive movement [ 10 ]. It necessitates less active participation from the patient. In clinical practice, Schroth exercise typically involves active breathing and postural adjustments guided by a physician or self-exercise at home. The variability in standardized movement levels during Schroth exercise among individuals may impact the consistent efficacy of the exercise. This variance in cooperation requirements prompted our investigation into a manipulation with lower cooperation demands. Traditional Chinese medicine (TCM) posits a close connection between spinal diseases and the "imbalance of tendons and bones" [ 36 ]. Hence, maintaining the objective stability of tendons and bones is pivotal in idiopathic scoliosis (IS) treatment [ 37 ]. TCM manipulation—LPM—is aligned with this theoretical foundation. In this study, we chose to use Cobb angle and AVT to measure "bone" and muscle tone and PPT to measure "tendon". We will be able to use different interventions for different clinical situations in the future by observing the effects of different maneuvers on these outcomes. The study hypothesis posits that both groups will exhibit improvements in muscle tone, PPT, and quality of life. The traditional massage combined with lever positioning manipulation group is expected to outperform the traditional massage combined with Schroth exercise group in reducing Cobb angle, AVT, muscle tone, and PPT. Should the final results align with the study hypothesis, LPM could be recommended for patients with more significant scoliotic angles, while those with milder scoliosis may find self-Schroth exercise at home more convenient. In terms of age, LPM may better serve as a passive therapy for younger, less cooperative patients, whereas Schroth exercise can be a suitable home exercise method for more compliant adult patients. It is generally recognized that Cobb angles greater than 30 degrees have a greater impact on the quality of life of patients with pain, cosmetic deformity and pulmonary disease. In future studies, we may focus on patients with Cobb angles between 30 degrees and 40 degrees. We will observe how effective LPM is in these patients with more severe scoliosis, and whether it can be used to replace, to a certain extent, rigid braces that have poor aesthetics and a greater impact on the quality of life. Declarations Contributors: ZW organized the data and wrote major contributions. ZL designed the study. LL revised the manuscript. KW, XZ, LC were responsible for the analysis of the data. SW, ZH were responsible for the inclusion of the patients in the subgroups. QX, TL, YH were responsible for the data collection. ZL was responsible for overall content. Funding: This study was supported by the National Natural Science Foundation of China(82274672); Zhejiang Province "vanguard" "leading goose" research and development plan project(2022C03123); Science and Technology Program of Traditional Chinese Medicine of Zhejiang Province(2023ZF024, 2023ZL469); Lv Lijiang Famous Elderly Chinese Medicine Specialist Inheritance Workshop (GZS2021026). Competing interests: None declared. Patient and public involvement: Patients and/or the public were not involved in the design, conduct, reporting, or dissemination plans for this study. Patient consent for publication: Not applicable. References Negrini S, Minozzi S, Bettany-Saltikov J, et al. Braces for Idiopathic Scoliosis in Adolescents. Spine (Phila Pa 1976). 2016;41(23):1813–25. Mohamed RA, Yousef AM. Impact of Schroth three-dimensional vs. proprioceptive neuromuscular facilitation techniques in adolescent idiopathic scoliosis: a randomized controlled study. Eur Rev Med Pharmacol Sci. 2021;25(24):7717–25. Lam TP, Ng BK, Cheung LW, et al. Effect of whole body vibration (WBV) therapy on bone density and bone quality in osteopenic girls with adolescent idiopathic scoliosis: a randomized, controlled trial. Osteoporos Int. 2013;24(5):1623–36. Peng Y, Wang SR, Qiu GX, et al. Research progress on the etiology and pathogenesis of adolescent idiopathic scoliosis. Chin Med J (Engl). 2020;133(4):483–93. Weinstein SL, Dolan LA, Wright JG, et al. Effects of bracing in adolescents with idiopathic scoliosis. N Engl J Med. 2013;369(16):1512–21. Schreiber S, Parent EC, Hedden DM, et al. Effect of Schroth exercises on curve characteristics and clinical outcomes in adolescent idiopathic scoliosis: protocol for a multicentre randomised controlled trial. J Physiother. 2014;60(4):234. Bettany-Saltikov J, Parent E, Romano M, et al. Physiotherapeutic scoliosis-specific exercises for adolescents with idiopathic scoliosis. Eur J Phys Rehabil Med. 2014;50(1):111–21. Xia HG, Wang DD, Xie JX, et al. The effect of orthopedic manipulation combined with Schroth training method in adolescent idiopathic scoliosis. J Cervicodynia Lumbodynia. 2022;43(04):594–6. Lu YL, Luo GG, Xie HF, et al. Rehabilitative Effects of Schroth Therapy with Bonesetting Massage for Adolescent Idiopathic Scoliosis. Chin Gen Pract. 2022;25(32):4059–64. Liu D, Lv LJ, Wang WW, et al. Lv Lijiang's experience in treating adolescent idiopathic scoliosis using lever positioning maneuver combined with pulsed electric field. Zhejiang J Traditional Chin Med. 2019;54(01):36–7. Lv LJ, Mao LY, Li JH, et al. Lever positioning manipulation combined with pulsed electric field on the analgesic effect of patients with lumbar disc herniation and its influence on IL-1β and TNF།α. China J Orthop Traumatol. 2021;34(08):780–4. Zhou XC, Huang YB, Wu S, et al. Lever positioning manipulation alters real-time brain activity in patients with lumbar disc herniation: An amplitude of low-frequency fluctuation and regional homogeneity study. Psychiatry Res Neuroimaging. 2023;334:111674. Lv LJ, LI JH, Yang C, et al. Clinical effect of lever positioning manipulation for lumbar disc herniation and its influence on Cobb angle. China J Orthop Traumatol. 2021;34(01):86–90. Zhang HY, Mao YL, Lv LJ. Research on the changes of sagittal parameters of spine and pelvis in patients with adolescent idiopathic scoliosis based on lever positioning manipulation. China Mod Doctor. 2022;60(04):147–50. Negrini S, Donzelli S, Aulisa AG, et al. 2016 SOSORT guidelines: Orthopaedic and rehabilitation treatment of idiopathic scoliosis during growth[J]. Scoliosis Spinal Disord. 2018;13:1–48. Han M, Wang Y, Zhang Y, et al. A multicomponent digital intervention to promote help-seeking for mental health problems and suicide in sexual and gender diverse young adults: A randomized controlled trial. PLoS Med. 2023;20(3):e1004197. Wei H, Xu J, Jiang Z, et al. Effect of a Traditional Chinese Medicine combined therapy on adolescent idiopathic scoliosis: a randomized controlled trial. J Tradit Chin Med. 2015;35(5):514–9. Lenhart-Schroth C. Three-dimensional treatment for scoliosis: A physiotherapeutic method for deformities of the spine. 1 ed. English Ed. California, Martindale Press; 2007. Deacon P, Flood B, Dickson R. Idiopathic scoliosis in three dimensions. A radiographic and morphometric analysis. J bone joint Surg Br volume. 1984;66(4):509–12. Wang B, Sun Y, Guo X, et al. The efficacy of 3D personalized insoles in moderate adolescent idiopathic scoliosis: a randomized controlled trial. BMC Musculoskelet Disord. 2022;23(1):983. Ceballos-Laita L, Carrasco-Uribarren A, Cabanillas-Barea S, et al. The effectiveness of Schroth method in Cobb angle, quality of life and trunk rotation angle in adolescent idiopathic scoliosis: a systematic review and meta-analysis. Eur J Phys Rehabil Med. 2023;59(2):228–36. Liu Y, Pan A, Hai Y, Li W, Yin L, Guo R. Asymmetric biomechanical characteristics of the paravertebral muscle in adolescent idiopathic scoliosis. Clin Biomech (Bristol Avon). 2019;65:81–6. Suzuki H, Tahara S, Mitsuda M, et al. Current Concept of Quantitative Sensory Testing and Pressure Pain Threshold in Neck/Shoulder and Low Back Pain. Healthc (Basel). 2022;10(8):1485. Teles AR, Ocay DD, Bin Shebreen A, et al. Evidence of impaired pain modulation in adolescents with idiopathic scoliosis and chronic back pain. Spine J. 2019;19(4):677–86. Baymurat AC, Daldal I, Tokgoz MA, et al. The effect of brace on apical vertebral derotation in adolescent idiopathic scoliosis. Spine Deform. 2023;11(5):1101–7. Pellegrino LN, Avanzi O. Prospective evaluation of quality of life in adolescent idiopathic scoliosis before and after surgery. J Spinal Disord Tech. 2014;27(8):409–14. Fairbank JC, Pynsent PB. The Oswestry Disability Index. Spine (Phila Pa 1976). 2000;25(22):2940–52. Bokshan SL, Godzik J, Dalton J, et al. Reliability of the revised Scoliosis Research Society-22 and Oswestry Disability Index (ODI) questionnaires in adult spinal deformity when administered by telephone. Spine J. 2016;16(9):1042–6. Repo JP, Ponkilainen VT, Häkkinen AH, et al. Assessment of Construct Validity of the Oswestry Disability Index and the Scoliosis Research Society-30 Questionnaire (SRS-30) in Patients With Degenerative Spinal Disease. Spine Deform. 2019;7(6):929–36. Hang X, Lv LJ, YING XM, et al. Clinical Research on Treating Idiopathic Scoliosis by Lever Positioning Manipulation and Schroth Method. J Zhejiang Chin Med Univ. 2020;44(11):1047–53. Thomas JJ, Stans AA, Milbrandt TA, et al. Trends in Incidence of Adolescent Idiopathic Scoliosis: A Modern US Population-based Study. J Pediatr Orthop. 2021;41(6):327–32. Sung S, Chae HW, Lee HS, et al. Incidence and Surgery Rate of Idiopathic Scoliosis: A Nationwide Database Study. Int J Environ Res Public Health. 2021;18(15):8152. Dobosiewicz K, Durmala J, Kotwicki T. Dobosiewicz method physiotherapy for idiopathic scoliosis. Stud Health Technol Inform. 2008;135:228–36. Mamyama T, Kitagawal T, Takeshita K, et al. Side shift exercise for idiopathic scoliosis after skeletal maturity. Stud Health Technol Inform. 2002;91:361–4. Dimitrijević V, Viduka D, Šćepanović T, et al. Effects of Schroth method and core stabilization exercises on idiopathic scoliosis: a systematic review and meta-analysis. Eur Spine J. 2022;31(12):3500–11. Ben CAO, Xin ZHOU, Jun REN, et al. Study on the characteristics of muscle-bone imbalance and inflammatory infiltration in lumbar disc herniation. China J Traditional Chin Med Pharm. 2023;38(10):4959–63. Robert J, Kowalski LA, Ferrara, Edward C, Benzel. Biomechanics of the spine. Neurosurg Q. 2005;15(1):42–9. Additional Declarations No competing interests reported. Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-3848605","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Study protocol","associatedPublications":[],"authors":[{"id":266268797,"identity":"9a205d90-37c8-4c02-b99d-936fa77daa3a","order_by":0,"name":"Zicheng Wei","email":"","orcid":"","institution":"Zhejiang Chinese Medical University","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Zicheng","middleName":"","lastName":"Wei","suffix":""},{"id":266268798,"identity":"3e671a70-8896-42d7-8d8e-c8f1ecb19c99","order_by":1,"name":"Kaizheng Wang","email":"","orcid":"","institution":"Zhejiang Chinese Medical University","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Kaizheng","middleName":"","lastName":"Wang","suffix":""},{"id":266268799,"identity":"9e925b5d-f0be-483a-ab11-1e76256861b1","order_by":2,"name":"Xingchen Zhou","email":"","orcid":"","institution":"Zhejiang Chinese Medical University","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Xingchen","middleName":"","lastName":"Zhou","suffix":""},{"id":266268800,"identity":"dedc919c-8169-47bc-808d-0ce7954c984a","order_by":3,"name":"Longhao Chen","email":"","orcid":"","institution":"Zhejiang Chinese Medical University","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Longhao","middleName":"","lastName":"Chen","suffix":""},{"id":266268801,"identity":"1e74dbe9-0e54-4ebe-9c56-2bc55b7c09c5","order_by":4,"name":"Shuang Wu","email":"","orcid":"","institution":"Zhejiang Chinese Medical University","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Shuang","middleName":"","lastName":"Wu","suffix":""},{"id":266268802,"identity":"374623ea-31b1-47e8-9e10-7c9d59de5542","order_by":5,"name":"Zihan Hua","email":"","orcid":"","institution":"Zhejiang Chinese Medical University","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Zihan","middleName":"","lastName":"Hua","suffix":""},{"id":266268803,"identity":"9072e83b-dcc5-4550-9469-91c4a6fc2993","order_by":6,"name":"Qiong Xia","email":"","orcid":"","institution":"Zhejiang Chinese Medical University","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Qiong","middleName":"","lastName":"Xia","suffix":""},{"id":266268804,"identity":"eb1fa2cc-b962-473f-bbfb-f878a4e3eb31","order_by":7,"name":"Tao Li","email":"","orcid":"","institution":"Zhejiang Chinese Medical University","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Tao","middleName":"","lastName":"Li","suffix":""},{"id":266268805,"identity":"88cc0789-a6b6-4ba5-b0b2-205e003a2f54","order_by":8,"name":"Yuanshen Huang","email":"","orcid":"","institution":"Zhejiang Chinese Medical University","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Yuanshen","middleName":"","lastName":"Huang","suffix":""},{"id":266268806,"identity":"9fd5f9c1-9ed0-47c6-8de5-220e9977825f","order_by":9,"name":"Lijiang Lv","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAA70lEQVRIiWNgGAWjYBACPgbmhgMSBkAWM/PBBx8qJOTkCWlhY2CEamFvSzacccbC2LCBCC0QFs8ZM2netopEhgOEtEgkNh6wKLDLk49IMDacOU8igbGB+eGjG/i1gByWXGx4IyHxwcdtEnnsDGzGxjn4tPAcBGlhTtw4I+Gw4cxtEsWMDTxs0kRoqQdqSWyT5p0DspSQFvZGkJbDifN5DrNJ8zYQr+V44gb2NmbDGcckjA2bCfiFn5n58GeJP9WJ85v5Pz74UFMnJ8/e/PAxPi0gwCwBJAwOwLkElIMA4wcgId9AhMpRMApGwSgYmQAAb99OUy92G1IAAAAASUVORK5CYII=","orcid":"","institution":"Zhejiang Chinese Medical University","correspondingAuthor":true,"submittingAuthor":false,"prefix":"","firstName":"Lijiang","middleName":"","lastName":"Lv","suffix":""},{"id":266268807,"identity":"41f18555-106c-49a4-823e-cdd07702c810","order_by":10,"name":"Zhizhen Lv","email":"","orcid":"","institution":"Zhejiang Chinese Medical University","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Zhizhen","middleName":"","lastName":"Lv","suffix":""}],"badges":[],"createdAt":"2024-01-09 15:14:16","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-3848605/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-3848605/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":49504149,"identity":"a27ebf62-8945-4ed7-9b97-ccc67fedd700","added_by":"auto","created_at":"2024-01-12 02:38:52","extension":"png","order_by":1,"title":"Figure 1","display":"","copyAsset":false,"role":"figure","size":418860,"visible":true,"origin":"","legend":"\u003cp\u003eFlow diagram of the study\u003c/p\u003e","description":"","filename":"floatimage2.png","url":"https://assets-eu.researchsquare.com/files/rs-3848605/v1/8c37cb8e5444f5e7cffe46b5.png"},{"id":49504150,"identity":"c64a248f-9a31-4ba7-a143-bb52fd165dd4","added_by":"auto","created_at":"2024-01-12 02:38:52","extension":"png","order_by":2,"title":"Figure 2","display":"","copyAsset":false,"role":"figure","size":865831,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eOperation diagram of lever positioning manipulation\u003c/strong\u003e\u003c/p\u003e","description":"","filename":"floatimage3.png","url":"https://assets-eu.researchsquare.com/files/rs-3848605/v1/ab06beca84b1f1269b43728a.png"},{"id":64932222,"identity":"00c4e218-fea7-4e20-8314-2ed50ac26a9e","added_by":"auto","created_at":"2024-09-20 14:08:16","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":1609709,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-3848605/v1/35a9b3f1-6c18-48a3-8cfc-9ce74e0d59b2.pdf"}],"financialInterests":"No competing interests reported.","formattedTitle":"The effects of lever positioning manipulation versus schorth exercise in idiopathic scoliosis: a protocol for a randomized clinical trial (RCT)","fulltext":[{"header":"Introduction","content":"\u003cp\u003eIdiopathic scoliosis is a common clinical disease of the bone and joint system [\u003cspan citationid=\"CR1\" class=\"CitationRef\"\u003e1\u003c/span\u003e]. Due to some reasons, one or several segments of the spine have deformation, lateral curvature and rotation deformity on the tubular plane that is different from the normal physiological curvature, so that the spine loses its original structure, and is often accompanied by neuromuscular or skeletal diseases [\u003cspan citationid=\"CR2\" class=\"CitationRef\"\u003e2\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR3\" class=\"CitationRef\"\u003e3\u003c/span\u003e]. Scoliosis can be divided into three main categories from the etiological point of view, which are congenital, neuromyogenic and idiopathic scoliosis, of which idiopathic account for 85%. Clinical treatment often takes into account the growth and development of adolescents and the harm of surgical trauma, and tries to adopt conservative treatment when the Cobb Angle is not greater than 40\u0026deg; [\u003cspan citationid=\"CR4\" class=\"CitationRef\"\u003e4\u003c/span\u003e]. However, conservative treatment also has several clinical problems, such as brace therapy requires long daily wear to be effective, as well as clinical problems such as long cycles and poor compliance among adolescents [\u003cspan citationid=\"CR5\" class=\"CitationRef\"\u003e5\u003c/span\u003e].\u003c/p\u003e \u003cp\u003eSchroth exercise represents a targeted corrective training approach designed for scoliosis management [\u003cspan citationid=\"CR6\" class=\"CitationRef\"\u003e6\u003c/span\u003e]. The underlying principle involves the deliberate alteration of body postures to open up the concave side of the scoliosis, facilitating the extension of the spine along its longitudinal axis. This corrective measure aims to realign the spine as closely as possible to the midline while incorporating helical angular respiration to address the rotational deformities induced by scoliosis and enhance thoracic expansion [\u003cspan citationid=\"CR7\" class=\"CitationRef\"\u003e7\u003c/span\u003e]. Schroth exercise, as a scoliosis-specific exercise therapy, has a positive significance on scoliosis patients. Its benefits encompass the ability to arrest the progression of scoliotic curves, alleviate lower back pain, augment lung capacity, refine posture, and elevate overall quality of life [\u003cspan citationid=\"CR8\" class=\"CitationRef\"\u003e8\u003c/span\u003e]. However, Schroth exercise still has shortcomings in the treatment of scoliosis correction. First, this treatment requires patients to train continuously and effectively for a long period of time, and due to the boring training process and the heavy school workload of adolescents, the long-term compliance of patients is poor; second, due to the low age of most patients, it is difficult to grasp the details of each training movement, which often fails to achieve the effect of the training of the target muscle groups [\u003cspan citationid=\"CR9\" class=\"CitationRef\"\u003e9\u003c/span\u003e]. Therefore, a kind of maneuver with good long-term compliance and low requirements for patients' own cooperation is urgently needed to be explored and tested. Notably, no prior studies have undertaken a comparative analysis between Traditional Chinese Medicine (TCM) manipulation and Schroth therapy, specifically assessing their impacts on muscle tissue condition, pain levels, and overall quality of life.\u003c/p\u003e \u003cp\u003eLever positioning manipulation (LPM) is a complementary therapy for spine-related disorders that is widely used in China [\u003cspan citationid=\"CR10\" class=\"CitationRef\"\u003e10\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR11\" class=\"CitationRef\"\u003e11\u003c/span\u003e]. LPM is usually performed by a physician trained in specialized manipulation. LPM involves the application of controlled forces by hand to the patient's paravertebral muscles and spine, with the aim of correcting abnormal bone positions and alleviating associated pain. LPM is able to affect sensory and emotional pain management in patients with LDH through prefrontal cortex, and primary somatosensory cortex regions of brain [\u003cspan citationid=\"CR12\" class=\"CitationRef\"\u003e12\u003c/span\u003e]. Recent investigations in 2021 have substantiated the efficacy of LPM in ameliorating Cobb's angle in LDH patients with the appearance of \"scoliosis\" [\u003cspan citationid=\"CR13\" class=\"CitationRef\"\u003e13\u003c/span\u003e]. Building upon this, a subsequent study demonstrated the positive impact of lever positioning manipulation on enhancing spino-pelvic sagittal parameters in individuals with Idiopathic Scoliosis (IS) [\u003cspan citationid=\"CR14\" class=\"CitationRef\"\u003e14\u003c/span\u003e]. As an external treatment of traditional Chinese medicine, leverage positioning technique has a good clinical effect on idiopathic scoliosis, which has been confirmed in the preliminary clinical study. Therefore, the purpose of this clinical trial was to evaluate and compare the effects of two treatment regimens on Cobb angle, apical vertebral translation (AVT), muscle tone, pressure pain threshold (PPT), quality of life (SF-36\u003cb\u003e)\u003c/b\u003e, Oswestry disability index (ODI) and clinical efficiency in patients with AIS.\u003c/p\u003e"},{"header":"Methods","content":"\u003cdiv id=\"Sec3\" class=\"Section2\"\u003e\n\u003ch2\u003eStudy design:\u003c/h2\u003e\n\u003cp\u003eThe study will recruit 102 subjects aged 12\u0026ndash;45 years from patients diagnosed with idiopathic scoliosis in the Third Hospital of Zhejiang University of Traditional Chinese Medicine. The researcher will divide the eligible subjects into 2 groups by using a randomized numeric table.\u003c/p\u003e\n\u003cp\u003eEach group would receive the corresponding intervention, each exercise program was performed three times a week and continued for 8 weeks. Outcome indicators would be assessed before and after intervention. A detailed account of the examinations, tests, or interventions administered at various time points is provided in \u003cstrong\u003eTable\u0026nbsp;1\u003c/strong\u003e.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eResult\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eData integration, processing and analysis will be performed by different designated researchers in this project at the end of all interventions as well as follow-up processes. The flowchart of this experiment is shown in Fig.\u0026nbsp;\u003cspan class=\"InternalRef\"\u003e1\u003c/span\u003e.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eParticipants\u003c/strong\u003e: This study will recruit IS patients who meet diagnostic criteria and eligibility criteria. Recruitment will be carried out by a single physician and an informed conversation will take place either in the consultation room or in the reception room of the wards. Participation in this study is entirely voluntary and patients may refuse to participate in this study or withdraw from the trial at any time without penalty or loss of benefits. If there is any important new information during the course of the trial that may affect the patient's willingness to continue participating in the study, the physician will inform the participants promptly. (The patient's legal representative will be notified when the patient is under 18 years of age). Before the patient makes the decision to participate in the trial, the physician will inform the subject of all aspects of the trial, and the subject may ask the physician questions about it until the subject fully understands the trial study.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eDiagnostic criteria\u003c/strong\u003e: According to the International Scoliosis Research Society (SRS) standards [\u003cspan class=\"CitationRef\"\u003e15\u003c/span\u003e]: ①adolescents without congenital diseases and a clear history of trauma; ②physical examination: the trunk is obviously asymmetric, the spine is scoliosis deformity; ③imaging: the patient's full-length orthopantomogram of the spine shows that Cobb's angle is \u0026ge;\u0026thinsp;10\u0026deg;; ④may be accompanied by local pain, aching and swelling and other sensory abnormalities.\u003c/p\u003e\n\u003c/div\u003e\n\u003cdiv id=\"Sec4\" class=\"Section2\"\u003e\n\u003ch2\u003eEligibility criteria\u003c/h2\u003e\n\u003cdiv id=\"Sec5\" class=\"Section3\"\u003e\n\u003ch2\u003eInclusion criteria\u003c/h2\u003e\n\u003cp\u003e①Meet the diagnostic criteria of scoliosis; ②Age is 12\u0026ndash;45 years old; ③Agree to participate in this study, accept the treatment of this program, sign the informed consent form and be able to cooperate with the follow-up; ④Be able to cooperate with the examination of spine radiograph and perform the measurement of Cobb angle and other related indexes; ⑤10\u0026deg; \u0026le; Cobb angle\u0026thinsp;\u0026le;\u0026thinsp;40\u0026deg;; ⑥Patient's scoliotic segment is one of the three of thoracic, thoracolumbar and lumbar segments.\u003c/p\u003e\n\u003c/div\u003e\n\u003cdiv id=\"Sec6\" class=\"Section3\"\u003e\n\u003ch2\u003eExclusion criteria\u003c/h2\u003e\n\u003cp\u003e①scoliosis progressed to the serious impact on cardiopulmonary function, is not suitable for conservative treatment; ②congenital scoliosis, spinal deformity, or the spine combined with vertebral body slippage, tumors, tuberculosis, bone fracture disease; ③combined with rheumatism, neuromuscular disease, cardiovascular disease, pulmonary disease or renal disease; ④Those who have undergone corrective spinal surgery; ⑤suffering from skin-related diseases and are unable to perform manipulation; ⑥Those who are suffering from mental illness or poor clinical compliance; ⑦Those who have not followed the prescribed treatment and are unable to judge the efficacy of the treatment, or those whose data are incomplete and affect the judgment of the efficacy of the treatment.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eTable\u0026nbsp;\u003c/strong\u003e\u003cstrong\u003e1\u003c/strong\u003e Diagram of research design\u003c/p\u003e\n\u003cp\u003e\u003cimg src=\"data:image/png;base64,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\" alt=\"\" /\u003e\u003c/p\u003e\n\u003cp\u003e\u0026times;: Indicates that this intervention program is being conducted at this point in timeline\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u0026nbsp;\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRandomization and Blinding\u003c/strong\u003e: After the patients who meet the diagnostic criteria and have been screened for inclusion and exclusion have agreed to participate in this study, the researcher will group the subjects using a random number table method [\u003cspan class=\"CitationRef\"\u003e16\u003c/span\u003e]. Each enrolled participant will be assigned a number generated through SPSS version 25.0, with each number corresponding to a specific treatment group. An investigator not involved in the intervention step will randomize the enrolled subjects into groups. Manipulations in this study will be performed by an acupuncture and massage practitioner with 5 years of clinical experience. This practitioner will be trained to perform Tuina, lever positioning manipulation, and Schroth exercise. Blinding of patients was not feasible due to the substantial variability in intervention modalities between the lever positioning maneuver and Schroth exercise. Patient blinding was not implemented for routine acupressure maneuvers, ensuring that the practitioner was aware of the patient's name but not their group enrollment. In addition, the intervention, efficacy assessment, and statistical analysis were performed by different designated researchers in this project. Statistical analysis will be performed by a professional statistician.\u003c/p\u003e\n\u003c/div\u003e\n\u003cdiv id=\"Sec7\" class=\"Section3\"\u003e\n\u003ch2\u003eIntervention groups\u003c/h2\u003e\n\u003cp\u003eWe plan to set up 2 study groups in this study. The interventions that 2 treatment groups will receive are:\u003c/p\u003e\n\u003cp\u003e①Tuina combine lever positioning manipulation\u003c/p\u003e\n\u003cp\u003e②Tuina combine schorth exercise\u003c/p\u003e\n\u003cp\u003eEach exercise program was performed three times a week on Sunday, Tuesday, and Thursday of each week. Cobb angle, AVT, muscle tone, PPT, ODI, quality of life, and clinical efficiency would be assessed before and after the \"8 weeks\" intervention.\u003c/p\u003e\n\u003c/div\u003e\n\u003c/div\u003e\n\u003cdiv id=\"Sec8\" class=\"Section2\"\u003e\n\u003ch2\u003eIntervention manipulation\u003c/h2\u003e\n\u003cdiv id=\"Sec9\" class=\"Section3\"\u003e\n\u003ch2\u003eTuina\u003c/h2\u003e\n\u003cp\u003eThe patient was placed in the prone position, exposing the back. The doctor used the rolling manipulation with a frequency of 100\u0026ndash;120 times/min, the flicking manipulation with a frequency of 120\u0026ndash;160 times/min, the pressing and kneading manipulation with a frequency of 120\u0026ndash;150 times/min. These manipulations will be operated on the Du channel (GV) and both sides of the Bladder channels (BL) [\u003cspan class=\"CitationRef\"\u003e17\u003c/span\u003e]. Attention was paid to the presence or absence of nodules, spasm points and other abnormal reaction points. Doctor were focused on the treatment for the lesion segments. Then, acupoints on both sides of the spine will be operated by pressing and kneading manipulation, which lasted for about 15 min. The exact location for each point will be determined based on the 2006 People\u0026rsquo;s Republic of China National Standard: The Name and Location of Acupoints (GB/T 12 346\u0026ndash;2006).\u003c/p\u003e\n\u003c/div\u003e\n\u003cdiv id=\"Sec10\" class=\"Section3\"\u003e\n\u003ch2\u003eLever positioning manipulation\u003c/h2\u003e\n\u003cp\u003eThe patient is placed in the prone position and the scoliosis area is exposed. Combined with X-ray examination, the scoliosis parietal vertebrae area is used as the positioning point for the doctor's operation. Make the patient relax, keep the lower limbs straight, the assistant hold the patient's knees and raise the patient's lower limbs and bend them toward the convex side of the spine to stretch the concave muscles. Then, the doctor with the elbow eagle's beak positioned next to the patient's parietal vertebrae, ask the patient to open his mouth and exhale. The doctor and the assistant simultaneously apply pressure in the opposite direction to the convex side of the spine at the same time, When pulling upwards to the trigger point, the practitioner pulls with a lever quickly with a technique and then senses a clatter or looseness at the positioning point [\u003cspan class=\"CitationRef\"\u003e12\u003c/span\u003e]. Repeat this procedure 3 times. The doctor and patient need to work closely together, patient should do not hold breath. Finally make the patient supine rest for 30min. The operation diagram of lever positioning manipulation was shown in Fig.\u0026nbsp;\u003cspan class=\"InternalRef\"\u003e2\u003c/span\u003e.\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003c/div\u003e\n\u003c/div\u003e\n\u003cdiv id=\"Sec11\" class=\"Section2\"\u003e\n\u003ch2\u003eSchroth exercise\u003c/h2\u003e\n\u003cp\u003eTake scoliosis with right lateral convexity as an example, the patient takes the natural standing position. If the patient's spine is in three arcs (one main and two compensatory arcs), flex the left hip joint, move the pelvis right under the thoracic convexity side, and support the body with the right leg. If the patient is in four arcs (two main and two compensatory arcs), flex the right hip joint, move the pelvis left under the thoracic concavity side, and support the body with the left leg. Moving the thorax left and stretching the concave side of the spine, direct the gas into the concave side as you inhale and push the convex side of the spine toward the opposite side [\u003cspan class=\"CitationRef\"\u003e18\u003c/span\u003e]. After reaching the desired position breathe in while tightening the trunk muscles forcefully. Repeat 20 times as one treatment, and the course of treatment was the same as the test group.\u003c/p\u003e\n\u003c/div\u003e\n\u003cdiv id=\"Sec12\" class=\"Section2\"\u003e\n\u003ch2\u003eOutcome measures\u003c/h2\u003e\n\u003cdiv id=\"Sec13\" class=\"Section3\"\u003e\n\u003ch2\u003ePrimary outcome measures\u003c/h2\u003e\n\u003cp\u003e\u003cstrong\u003eCobb angle\u003c/strong\u003e Took a standard anterior-posterior standing full spine radiograph [\u003cspan class=\"CitationRef\"\u003e19\u003c/span\u003e] to measure the Cobb angle [\u003cspan class=\"CitationRef\"\u003e20\u003c/span\u003e], the major one curve will be measured. The Cobb angle is the most commonly used indicator of IS. Orthopedic surgeons and physical therapists use the Cobb angle to determine the patient's condition and assign treatment goals, and improvements in the Cobb angle directly reduce the need for surgery [\u003cspan class=\"CitationRef\"\u003e21\u003c/span\u003e].\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eMuscle tone\u003c/strong\u003e Studies have shown that paraspinal muscle tone is greater on the concave side than on the convex side in patients with idiopathic scoliosis. The severity of scoliosis is closely related to the asymmetric biomechanical characteristics of the paravertebral muscles [\u003cspan class=\"CitationRef\"\u003e22\u003c/span\u003e]. In this study, muscle tone was measured using the Rapid Muscle Condition Measurement System (Ito Ultrashort Wave Co., Ltd., Japan, OE-220). The procedure was as follows: the room temperature was maintained at 25\u0026ndash;28 degrees Celsius, and the subjects were placed in the prone position with the low back exposed. The muscles tested were the erector spinae muscles bilaterally. The dystonia test points were calibrated on the erector spinae muscles at 1.5 cm from the largest segment of the scoliotic scoliosis and at 1.5 cm from the interspace between the upper and lower neighboring segments on each side, three on each side.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003ePressure pain threshold (PPT)\u003c/strong\u003e PPT stands as a frequently employed quantitative sensory testing (QST) parameter in the investigation of nociceptive sensitization. This quantifiable indicator, measurable by electronic instruments, possesses the distinct advantage of ease of measurement [\u003cspan class=\"CitationRef\"\u003e23\u003c/span\u003e]. It has been shown that the probability of impaired pain modulation is higher in AIS patients with chronic back pain symptoms. Measurement of the PPT can therefore provide some indication of the ability of different interventions to repair pain modulation [\u003cspan class=\"CitationRef\"\u003e24\u003c/span\u003e]. The PPT is measured in the same way as the Muscle tone. First, pressing the pressure probe vertically to the calibration point, the position was the same as that of the muscle tone. When the subject feels the pressure pain, he/she signals to the doctor, who immediately lifts the pressure probe. The PPT value is the peak value of the pressure. 3 measurements were taken on each side, then take the average value.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eClinical efficiency\u003c/strong\u003e The efficacy evaluation was based on the efficacy evaluation criteria of the 2018 version of the Chinese Medicine Diagnosis and Treatment Program for Adolescent Idiopathic Scoliosis issued by the Chiropractic Branch of the Chinese Society of Traditional Chinese Medicine. After the standard anterior-posterior standing full spine radiograph was taken again after treatment, the Cobb angle was compared before and after treatment. Apparent effect: scoliosis improved by more than 30\u0026deg;; Effective: scoliosis improved by \u0026ge;\u0026thinsp;5\u0026deg; and \u0026le;\u0026thinsp;30\u0026deg;; Ineffective: no improvement in scoliosis after 2 weeks of treatment.\u003c/p\u003e\n\u003c/div\u003e\n\u003c/div\u003e\n\u003cdiv id=\"Sec14\" class=\"Section2\"\u003e\n\u003ch2\u003eSecondary outcome measures\u003c/h2\u003e\n\u003cp\u003e\u003cstrong\u003eApical vertebral translation (AVT)\u003c/strong\u003e The main apical vertebral translation was measured by a standard anterior-posterior standing full spine radiograph. the AVT for thoracic curvature patients being the horizontal distance from the midpoint of the parietal vertebrae (or discs) to C7PL; and for thoracolumbar curvature and lumbar curvature being the AVT from the midpoint of the parietal vertebrae (or discs) to the CSVL horizontal distance. The left side of the parietal vertebrae bias toward the CSLV/C7PL is negative and the right side is positive [\u003cspan class=\"CitationRef\"\u003e25\u003c/span\u003e]. AVT can be used to determine the stability of the coronal position of the spine and has great significance in patients with scoliosis.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eQuality of life(SF-36)\u003c/strong\u003e The Medical Outcomes Study (MOS) Short Form Health Survey, commonly known as SF-36, serves as a concise health survey questionnaire. This instrument comprehensively assesses the quality of life across eight dimensions, encompassing physiological functioning, physical functioning, physical pain, general health status, energy, social functioning, emotional functioning, and mental health. In addition to these dimensions, SF-36 incorporates another health indicator\u0026mdash;health change, designed to evaluate the overall change in health status experienced by respondents over the past year [\u003cspan class=\"CitationRef\"\u003e26\u003c/span\u003e].\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eOswestry disability index(ODI)\u003c/strong\u003e The ODI is currently the more commonly used assessment indicatorin the management of spinal disorders [\u003cspan class=\"CitationRef\"\u003e27\u003c/span\u003e]. This scale assesses the level of low back pain, lumbar mobility function in patients with scoliosis and has been shown to be reliable in several studies [\u003cspan class=\"CitationRef\"\u003e28\u003c/span\u003e\u0026ndash;\u003cspan class=\"CitationRef\"\u003e29\u003c/span\u003e].\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eSample size\u003c/strong\u003e: Cobb's angle was used as the primary outcome indicator in this study, and we performed sample size estimation by comparing the mean difference(MD) and standard deviation (SD) of this indicator in two independent samples. We are based on relevant research [\u003cspan class=\"CitationRef\"\u003e30\u003c/span\u003e]. The MD of Cobb angle in group of lever positioning manipulation is 9.69 and the SD was 6.02. the MD of Cobb angle in control group is 13.84 and the SD was 8.21. we set type I error probability \u0026alpha;\u0026thinsp;=\u0026thinsp;0.05, type II error probability \u0026beta;\u0026thinsp;=\u0026thinsp;0.20, dropout rate\u0026thinsp;=\u0026thinsp;0.15, bilateral testing, a total of 51 participants were calculated to be recruited in each group.\u003c/p\u003e\n\u003c/div\u003e\n\u003cdiv id=\"Sec15\" class=\"Section2\"\u003e\n\u003ch2\u003eStatistical analysis:\u003c/h2\u003e\n\u003cp\u003eAll statistical analyses were conducted utilizing SPSS version 25.0. The comparison of subject measures employed either independent samples t-test or Mann-Whitney U-test (\u0026alpha;\u0026thinsp;=\u0026thinsp;0.05), as appropriate, while repeated-measures ANOVA was employed for assessments at multiple time points within groups. For demographic characteristics such as age and BMI, as well as primary outcomes, data normality was confirmed through Q-Q plots and Shapiro-Wilk tests. Count data, specifically the male-to-female ratio, underwent comparison via the chi-square test and Fisher's exact test, considering a two-sided p\u0026thinsp;\u0026lt;\u0026thinsp;0.05 as indicative of a statistically significant difference.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eSafety evaluation\u003c/strong\u003e: Any adverse medical event observed between the subject's informed consent signing and the final visit, irrespective of its causal relationship to the trial, is classified as an adverse event. An adverse event encompasses any unfavorable and undesired sign, symptom, or transient illness associated with treatment, regardless of its causal link to the intervention. Adverse events include the following: all suspected adverse reactions; soreness and discomfort in the lower back; obviously unrelated diseases, including exacerbations of pre-existing conditions; and abnormalities in physical examinations or laboratory tests requiring further investigations (excluding retesting).\u003c/p\u003e\n\u003cp\u003eA serious adverse event is defined as an occurrence during the study phase meeting one or more of the following criteria: death; being life-threatening; necessitating hospitalization or prolonged hospital stay; causing permanent or severe disability; or resulting in a congenital malformation or defect. Medical events that have not yet resulted in death, life-threatening conditions, or the need for hospitalization should also be deemed serious adverse events when deemed appropriate based on medical judgment.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAcquisition, observation and recording of adverse events\u003c/strong\u003e: Clinicians are required to promptly report all adverse events directly observed or spontaneously disclosed by the subjects, utilizing concise medical terminology. Additionally, subjects should be queried about adverse events each time they are assessed post the initiation of treatment to systematically gather trial data. In the occurrence of an adverse event, meticulous records must document the date of onset and resolution, the severity and outcome of the adverse event, a detailed description of the interventions employed, their causal relationship to the administered therapy, and any alternative factors unrelated to the therapy that may have contributed to the adverse event.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eTreatment of adverse events\u003c/strong\u003e: If any adverse event occurs during the clinical trial, regardless of whether it is causally related to the treatment method used, the investigator should take necessary measures to provide treatment and rescue. For adverse events, the type, degree, time of occurrence, duration, treatment measures, treatment process, etc. should be recorded in the hospitalized medical record and pathological report form, and comprehensively analyzed whether they are related to the trial. After the occurrence of an adverse event, the investigator may decide whether the subject should be terminated from the clinical trial according to the condition. Cases in which the trial was terminated due to serious adverse events should be tracked and followed up, and their regression should be recorded. In the event of a serious adverse event during the trial, regardless of whether it is related to the trial or not, first aid measures should be taken immediately and the principal investigator and the ethics committee should be notified by telephone within 24 hours. A serious adverse event report form should then be completed and promptly reported to the above authorities.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eData collection and monitoring\u003c/strong\u003e: Upon participant recruitment, the screener will gather baseline characteristic data and conduct measurements of both primary and secondary outcome indicators. Following the completion of the treatment period, the screener will reassess the primary and secondary outcome indicators, with all pertinent data meticulously recorded in the Case Report Form (CRF). During the follow-up visit after 60 days, participants will be requested to complete two questionnaires related to secondary outcome indicators, and the questionnaire results will be documented in the CRF. To ensure data accuracy and integrity, two data managers, blinded to the group assignments, will independently receive and enter completed CRF into an Excel database. These data managers have undergone rigorous training in data monitoring. Additionally, real-time data entry will be performed in the China Clinical Trial Registry, and an electronic data management system will facilitate continuous tracking and monitoring of test data at the Third Hospital Affiliated to Zhejiang University of Traditional Chinese Medicine.\u003c/p\u003e\n\u003c/div\u003e\n\u003cdiv id=\"Sec16\" class=\"Section2\"\u003e\n\u003ch2\u003eQuality control\u003c/h2\u003e\n\u003cp\u003eUniform testing standard operating procedures (SOP) will be developed by the study group. One month before the official launch of the clinical trial, the research group will hold a special training meeting to provide unified training for all researchers involved in the study. The main focus of the training is on the implementation of the program and the standard operating procedures (SOP). So that each clinical researcher is familiar with the research process and specific implementation details to ensure the reliability of the conclusions of the clinical study. All observations in the clinical study should be verified and repeatedly confirmed to ensure the reliability and originality of the data, and to ensure that all results and conclusions in the clinical study are derived from the original data. Specialized personnel should be employed for the collection of trial data and statistics to control trial bias. Appoint a professional data management company for clinical data management. Strictly implement the monthly clinical study quality inspection.\u003c/p\u003e\n\u003c/div\u003e\n\u003cdiv id=\"Sec17\" class=\"Section2\"\u003e\n\u003ch2\u003eEthics\u003c/h2\u003e\n\u003cp\u003eThe study was approved by the medical ethics committee of the Third Hospital of Zhejiang University of Traditional Chinese Medicine (No. ZSLL-KY-2023-051-01). And this project was registered with the Chinese Clinical Trial Registry (Registration number: ChiCTR2300077604.).\u003c/p\u003e\n\u003c/div\u003e\n\u003cdiv id=\"Sec18\" class=\"Section2\"\u003e\n\u003ch2\u003ePatient and public involvement\u003c/h2\u003e\n\u003cp\u003ePatients and/or the public were not involved in the design, conduct, reporting, or dissemination plans for this study.\u003c/p\u003e\n\u003c/div\u003e\n\u003cdiv id=\"Sec19\" class=\"Section2\"\u003e\n\u003ch2\u003eDissemination\u003c/h2\u003e\n\u003cp\u003eThe study will be disseminated through presentations in peer-reviewed international journals and at national and international conferences.\u003c/p\u003e\n\u003c/div\u003e"},{"header":"Discussion","content":"\u003cp\u003eThe incidence of adolescent idiopathic scoliosis (AIS) is on the rise, with a prevalence rate approximately twice as high in females as in males [\u003cspan citationid=\"CR31\" class=\"CitationRef\"\u003e31\u003c/span\u003e]. Only 0.7% of patients underwent surgical treatment within five years of onset due to clinical considerations of adolescent growth and development as well as the hazards of surgical trauma [\u003cspan citationid=\"CR32\" class=\"CitationRef\"\u003e32\u003c/span\u003e]. For AIS patients with a Cobb angle below 40\u0026deg;, conservative treatment remains the preferred option for the majority. Despite its widespread prevalence, the current evidential support for conservative treatment approaches for AIS is notably lacking. Alongside Schroth therapy, various mainstream exercise therapies, such as DoboMed therapy, have demonstrated the ability to impede the progression of the scoliotic curve, enhance respiratory function, and improve overall exercise efficiency [\u003cspan citationid=\"CR33\" class=\"CitationRef\"\u003e33\u003c/span\u003e]. In a study by Mamyama T et al [\u003cspan citationid=\"CR34\" class=\"CitationRef\"\u003e34\u003c/span\u003e], Side-Shift therapy was found to be more efficacious in treating IS after skeletal maturation. However, certain exercise therapies exhibit inconsistent therapeutic effects, with varying efficacy observed among individuals in research studies [\u003cspan citationid=\"CR35\" class=\"CitationRef\"\u003e35\u003c/span\u003e]. Consequently, there is a compelling need to explore conservative therapies with more reliable and stabilizing effects.\u003c/p\u003e \u003cp\u003eLPM is a treatment method in which the physician performs the manipulation and the patient's body undergoes passive movement [\u003cspan citationid=\"CR10\" class=\"CitationRef\"\u003e10\u003c/span\u003e]. It necessitates less active participation from the patient. In clinical practice, Schroth exercise typically involves active breathing and postural adjustments guided by a physician or self-exercise at home. The variability in standardized movement levels during Schroth exercise among individuals may impact the consistent efficacy of the exercise. This variance in cooperation requirements prompted our investigation into a manipulation with lower cooperation demands.\u003c/p\u003e \u003cp\u003eTraditional Chinese medicine (TCM) posits a close connection between spinal diseases and the \"imbalance of tendons and bones\" [\u003cspan citationid=\"CR36\" class=\"CitationRef\"\u003e36\u003c/span\u003e]. Hence, maintaining the objective stability of tendons and bones is pivotal in idiopathic scoliosis (IS) treatment [\u003cspan citationid=\"CR37\" class=\"CitationRef\"\u003e37\u003c/span\u003e]. TCM manipulation\u0026mdash;LPM\u0026mdash;is aligned with this theoretical foundation. In this study, we chose to use Cobb angle and AVT to measure \"bone\" and muscle tone and PPT to measure \"tendon\". We will be able to use different interventions for different clinical situations in the future by observing the effects of different maneuvers on these outcomes.\u003c/p\u003e \u003cp\u003eThe study hypothesis posits that both groups will exhibit improvements in muscle tone, PPT, and quality of life. The traditional massage combined with lever positioning manipulation group is expected to outperform the traditional massage combined with Schroth exercise group in reducing Cobb angle, AVT, muscle tone, and PPT. Should the final results align with the study hypothesis, LPM could be recommended for patients with more significant scoliotic angles, while those with milder scoliosis may find self-Schroth exercise at home more convenient. In terms of age, LPM may better serve as a passive therapy for younger, less cooperative patients, whereas Schroth exercise can be a suitable home exercise method for more compliant adult patients.\u003c/p\u003e \u003cp\u003eIt is generally recognized that Cobb angles greater than 30 degrees have a greater impact on the quality of life of patients with pain, cosmetic deformity and pulmonary disease. In future studies, we may focus on patients with Cobb angles between 30 degrees and 40 degrees. We will observe how effective LPM is in these patients with more severe scoliosis, and whether it can be used to replace, to a certain extent, rigid braces that have poor aesthetics and a greater impact on the quality of life.\u003c/p\u003e "},{"header":"Declarations","content":"\u003cp\u003e\u003cstrong\u003eContributors:\u003c/strong\u003e ZW organized the data and wrote major contributions. ZL designed the study. LL revised the manuscript. KW, XZ, LC were responsible for the analysis of the data. SW, ZH were responsible for the inclusion of the patients in the subgroups. QX, TL, YH were responsible for the data collection. ZL was responsible for overall content.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eFunding:\u003c/strong\u003e This study was supported by the National Natural Science Foundation of China(82274672); Zhejiang Province \u0026quot;vanguard\u0026quot; \u0026quot;leading goose\u0026quot; research and development plan project(2022C03123); Science and Technology Program of Traditional Chinese Medicine of Zhejiang Province(2023ZF024, 2023ZL469); Lv Lijiang Famous Elderly Chinese Medicine Specialist Inheritance Workshop (GZS2021026).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eCompeting interests:\u003c/strong\u003e None declared.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003ePatient and public involvement:\u0026nbsp;\u003c/strong\u003ePatients and/or the public were not involved in the design, conduct, reporting, or dissemination plans for this study.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003ePatient consent for publication:\u003c/strong\u003e Not applicable.\u003c/p\u003e"},{"header":"References","content":"\u003col\u003e\u003cli\u003e\u003cspan\u003eNegrini S, Minozzi S, Bettany-Saltikov J, et al. Braces for Idiopathic Scoliosis in Adolescents. Spine (Phila Pa 1976). 2016;41(23):1813\u0026ndash;25.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eMohamed RA, Yousef AM. Impact of Schroth three-dimensional vs. proprioceptive neuromuscular facilitation techniques in adolescent idiopathic scoliosis: a randomized controlled study. Eur Rev Med Pharmacol Sci. 2021;25(24):7717\u0026ndash;25.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eLam TP, Ng BK, Cheung LW, et al. Effect of whole body vibration (WBV) therapy on bone density and bone quality in osteopenic girls with adolescent idiopathic scoliosis: a randomized, controlled trial. Osteoporos Int. 2013;24(5):1623\u0026ndash;36.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003ePeng Y, Wang SR, Qiu GX, et al. Research progress on the etiology and pathogenesis of adolescent idiopathic scoliosis. Chin Med J (Engl). 2020;133(4):483\u0026ndash;93.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eWeinstein SL, Dolan LA, Wright JG, et al. Effects of bracing in adolescents with idiopathic scoliosis. N Engl J Med. 2013;369(16):1512\u0026ndash;21.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eSchreiber S, Parent EC, Hedden DM, et al. Effect of Schroth exercises on curve characteristics and clinical outcomes in adolescent idiopathic scoliosis: protocol for a multicentre randomised controlled trial. J Physiother. 2014;60(4):234.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eBettany-Saltikov J, Parent E, Romano M, et al. Physiotherapeutic scoliosis-specific exercises for adolescents with idiopathic scoliosis. Eur J Phys Rehabil Med. 2014;50(1):111\u0026ndash;21.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eXia HG, Wang DD, Xie JX, et al. The effect of orthopedic manipulation combined with Schroth training method in adolescent idiopathic scoliosis. J Cervicodynia Lumbodynia. 2022;43(04):594\u0026ndash;6.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eLu YL, Luo GG, Xie HF, et al. Rehabilitative Effects of Schroth Therapy with Bonesetting Massage for Adolescent Idiopathic Scoliosis. Chin Gen Pract. 2022;25(32):4059\u0026ndash;64.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eLiu D, Lv LJ, Wang WW, et al. Lv Lijiang's experience in treating adolescent idiopathic scoliosis using lever positioning maneuver combined with pulsed electric field. Zhejiang J Traditional Chin Med. 2019;54(01):36\u0026ndash;7.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eLv LJ, Mao LY, Li JH, et al. Lever positioning manipulation combined with pulsed electric field on the analgesic effect of patients with lumbar disc herniation and its influence on IL-1β and TNF།α. China J Orthop Traumatol. 2021;34(08):780\u0026ndash;4.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eZhou XC, Huang YB, Wu S, et al. Lever positioning manipulation alters real-time brain activity in patients with lumbar disc herniation: An amplitude of low-frequency fluctuation and regional homogeneity study. Psychiatry Res Neuroimaging. 2023;334:111674.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eLv LJ, LI JH, Yang C, et al. Clinical effect of lever positioning manipulation for lumbar disc herniation and its influence on Cobb angle. China J Orthop Traumatol. 2021;34(01):86\u0026ndash;90.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eZhang HY, Mao YL, Lv LJ. Research on the changes of sagittal parameters of spine and pelvis in patients with adolescent idiopathic scoliosis based on lever positioning manipulation. China Mod Doctor. 2022;60(04):147\u0026ndash;50.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eNegrini S, Donzelli S, Aulisa AG, et al. 2016 SOSORT guidelines: Orthopaedic and rehabilitation treatment of idiopathic scoliosis during growth[J]. Scoliosis Spinal Disord. 2018;13:1\u0026ndash;48.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eHan M, Wang Y, Zhang Y, et al. A multicomponent digital intervention to promote help-seeking for mental health problems and suicide in sexual and gender diverse young adults: A randomized controlled trial. PLoS Med. 2023;20(3):e1004197.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eWei H, Xu J, Jiang Z, et al. Effect of a Traditional Chinese Medicine combined therapy on adolescent idiopathic scoliosis: a randomized controlled trial. J Tradit Chin Med. 2015;35(5):514\u0026ndash;9.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eLenhart-Schroth C. Three-dimensional treatment for scoliosis: A physiotherapeutic method for deformities of the spine. 1 ed. English Ed. California, Martindale Press; 2007.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eDeacon P, Flood B, Dickson R. Idiopathic scoliosis in three dimensions. A radiographic and morphometric analysis. J bone joint Surg Br volume. 1984;66(4):509\u0026ndash;12.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eWang B, Sun Y, Guo X, et al. The efficacy of 3D personalized insoles in moderate adolescent idiopathic scoliosis: a randomized controlled trial. BMC Musculoskelet Disord. 2022;23(1):983.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eCeballos-Laita L, Carrasco-Uribarren A, Cabanillas-Barea S, et al. The effectiveness of Schroth method in Cobb angle, quality of life and trunk rotation angle in adolescent idiopathic scoliosis: a systematic review and meta-analysis. Eur J Phys Rehabil Med. 2023;59(2):228\u0026ndash;36.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eLiu Y, Pan A, Hai Y, Li W, Yin L, Guo R. Asymmetric biomechanical characteristics of the paravertebral muscle in adolescent idiopathic scoliosis. Clin Biomech (Bristol Avon). 2019;65:81\u0026ndash;6.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eSuzuki H, Tahara S, Mitsuda M, et al. Current Concept of Quantitative Sensory Testing and Pressure Pain Threshold in Neck/Shoulder and Low Back Pain. Healthc (Basel). 2022;10(8):1485.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eTeles AR, Ocay DD, Bin Shebreen A, et al. Evidence of impaired pain modulation in adolescents with idiopathic scoliosis and chronic back pain. Spine J. 2019;19(4):677\u0026ndash;86.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eBaymurat AC, Daldal I, Tokgoz MA, et al. The effect of brace on apical vertebral derotation in adolescent idiopathic scoliosis. Spine Deform. 2023;11(5):1101\u0026ndash;7.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003ePellegrino LN, Avanzi O. Prospective evaluation of quality of life in adolescent idiopathic scoliosis before and after surgery. J Spinal Disord Tech. 2014;27(8):409\u0026ndash;14.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eFairbank JC, Pynsent PB. The Oswestry Disability Index. Spine (Phila Pa 1976). 2000;25(22):2940\u0026ndash;52.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eBokshan SL, Godzik J, Dalton J, et al. Reliability of the revised Scoliosis Research Society-22 and Oswestry Disability Index (ODI) questionnaires in adult spinal deformity when administered by telephone. Spine J. 2016;16(9):1042\u0026ndash;6.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eRepo JP, Ponkilainen VT, H\u0026auml;kkinen AH, et al. Assessment of Construct Validity of the Oswestry Disability Index and the Scoliosis Research Society-30 Questionnaire (SRS-30) in Patients With Degenerative Spinal Disease. Spine Deform. 2019;7(6):929\u0026ndash;36.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eHang X, Lv LJ, YING XM, et al. Clinical Research on Treating Idiopathic Scoliosis by Lever Positioning Manipulation and Schroth Method. J Zhejiang Chin Med Univ. 2020;44(11):1047\u0026ndash;53.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eThomas JJ, Stans AA, Milbrandt TA, et al. Trends in Incidence of Adolescent Idiopathic Scoliosis: A Modern US Population-based Study. J Pediatr Orthop. 2021;41(6):327\u0026ndash;32.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eSung S, Chae HW, Lee HS, et al. Incidence and Surgery Rate of Idiopathic Scoliosis: A Nationwide Database Study. Int J Environ Res Public Health. 2021;18(15):8152.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eDobosiewicz K, Durmala J, Kotwicki T. Dobosiewicz method physiotherapy for idiopathic scoliosis. Stud Health Technol Inform. 2008;135:228\u0026ndash;36.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eMamyama T, Kitagawal T, Takeshita K, et al. Side shift exercise for idiopathic scoliosis after skeletal maturity. Stud Health Technol Inform. 2002;91:361\u0026ndash;4.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eDimitrijević V, Viduka D, Šćepanović T, et al. Effects of Schroth method and core stabilization exercises on idiopathic scoliosis: a systematic review and meta-analysis. Eur Spine J. 2022;31(12):3500\u0026ndash;11.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eBen CAO, Xin ZHOU, Jun REN, et al. Study on the characteristics of muscle-bone imbalance and inflammatory infiltration in lumbar disc herniation. China J Traditional Chin Med Pharm. 2023;38(10):4959\u0026ndash;63.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eRobert J, Kowalski LA, Ferrara, Edward C, Benzel. Biomechanics of the spine. Neurosurg Q. 2005;15(1):42\u0026ndash;9.\u003c/span\u003e\u003c/li\u003e\u003c/ol\u003e"}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"Idiopathic scoliosis, Lever positioning manipulation, Protocol, Cobb angle, Muscle tone, Pain threshold","lastPublishedDoi":"10.21203/rs.3.rs-3848605/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-3848605/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003e\u003cstrong\u003eBackground: \u003c/strong\u003eIdiopathic scoliosis is a prevalent clinical condition within the bone and joint system, commonly manifested in adolescents, significantly impacting their physical and mental well-being. Presently, conservative interventions constitute the primary therapeutic approach, encompassing modalities such as brace therapy, manipulation therapy, and exercise therapy. Nonetheless, challenges persist in the realm of conservative treatment, marked by issues of inconvenience and suboptimal adherence. This study endeavors to identify a manipulation technique that can potentially substitute or augment the efficacy of brace therapy or exercise therapy. The primary objective of this protocol is to delineate a randomized controlled trial aimed at scrutinizing and contrasting the outcomes resulting from a specific manipulation method (lever positioning manipulation) and a widely employed exercise therapy (Schroth exercise) in the management of idiopathic scoliosis.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eMethods：\u003c/strong\u003eThis is a randomized clinical trial, employing both assessor-blinding and analyst-blinding methodologies. This study is proposed to include 102 patients with idiopathic scoliosis. The 102 patients were divided into 2 groups of 51 cases each by randomized number table method. The groups consist of a traditional massage combined with lever positioning manipulation group and a traditional massage combined with Schroth exercise group. Each exercise regimen is administered thrice weekly over an 8-week duration. Outcome measures encompass the assessment of Cobb angle, apical vertebral translation (AVT), muscle tone, pressure pain threshold (PPT), quality of life (SF-36\u003cstrong\u003e)\u003c/strong\u003e, Oswestry disability index (ODI) and clinical efficiency. Evaluations are conducted at baseline, the conclusion of the treatment program, and during follow-up sessions. It will be observed whether the manipulation is superior compared to the schorth exercise and whether it can be used as an alternative treatment for scoliosis.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eDiscussion: \u003c/strong\u003eThe results of this study will tell clinicians what conservative therapy regimen will produce better clinical outcomes for patients with AIS.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eTrial registration: \u003c/strong\u003eThis project is registered with the Chinese Clinical Trial Registry，Registration number:\u003cstrong\u003e \u003c/strong\u003eChiCTR2300077604.\u003c/p\u003e","manuscriptTitle":"The effects of lever positioning manipulation versus schorth exercise in idiopathic scoliosis: a protocol for a randomized clinical trial (RCT)","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2024-01-12 02:38:48","doi":"10.21203/rs.3.rs-3848605/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"0c5b484e-84aa-498e-8a3f-15d16c38453a","owner":[],"postedDate":"January 12th, 2024","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[],"tags":[],"updatedAt":"2024-12-27T02:53:07+00:00","versionOfRecord":[],"versionCreatedAt":"2024-01-12 02:38:48","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-3848605","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-3848605","identity":"rs-3848605","version":["v1"]},"buildId":"ApUGefWb6u5IBVtyqm6d5","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}